Works matching IS 00099236 AND DT 2019 AND VI 106 AND IP 1
Results: 44
CORRIGENDUM: Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration‐QTc Relationships.
- Published in:
- 2019
- Publication type:
- Correction Notice
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 9, doi. 10.1002/cpt.1488
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 19, doi. 10.1002/cpt.1487
- Publication type:
- Article
What Does It Take to Transform Real‐World Data Into Real‐World Evidence?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 10, doi. 10.1002/cpt.1486
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 21, doi. 10.1002/cpt.1485
- Publication type:
- Article
Opportunities and Challenges of Using Big Data to Detect Drug‐Drug Interaction Risk.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 72, doi. 10.1002/cpt.1481
- By:
- Publication type:
- Article
A Structured Preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real‐World Evidence for Regulatory Decisions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 103, doi. 10.1002/cpt.1480
- By:
- Publication type:
- Article
Predictive Analysis of First Abbreviated New Drug Application Submission for New Chemical Entities Based on Machine Learning Methodology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 174, doi. 10.1002/cpt.1479
- By:
- Publication type:
- Article
Effect of Body Weight on Risk‐Benefit and Dosing Regimen Recommendation of Secukinumab for the Treatment of Moderate to Severe Plaque Psoriasis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 78, doi. 10.1002/cpt.1478
- By:
- Publication type:
- Article
Real‐World Data: An Unrealized Opportunity in Global Health?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 57, doi. 10.1002/cpt.1476
- By:
- Publication type:
- Article
Model‐Informed Drug Development: A Regulatory Perspective on Progress.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 91, doi. 10.1002/cpt.1475
- By:
- Publication type:
- Article
Small But Mighty: The Use of Real‐World Evidence to Inform Precision Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 87, doi. 10.1002/cpt.1466
- By:
- Publication type:
- Article
The Missing Reality of Real Life in Real‐World Evidence.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 136, doi. 10.1002/cpt.1465
- By:
- Publication type:
- Article
Using a Benefit–Risk Analysis Approach to Capture Regulatory Decision Making: Melanoma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 123, doi. 10.1002/cpt.1461
- By:
- Publication type:
- Article
Information Patients Can Provide Will Strengthen the Real‐World Evidence That Matters to Them.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 49, doi. 10.1002/cpt.1460
- By:
- Publication type:
- Article
Harnessing the Power of Collaboration and Training Within Clinical Data Science to Generate Real‐World Evidence in the Era of Precision Oncology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 60, doi. 10.1002/cpt.1459
- By:
- Publication type:
- Article
Liver Microphysiological Systems for Predicting and Evaluating Drug Effects.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 139, doi. 10.1002/cpt.1458
- By:
- Publication type:
- Article
The US Food and Drug Administration's Model‐Informed Drug Development Paired Meeting Pilot Program: Early Experience and Impact.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 74, doi. 10.1002/cpt.1457
- By:
- Publication type:
- Article
Decentralized Trials in the Age of Real‐World Evidence and Inclusivity in Clinical Investigations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 25, doi. 10.1002/cpt.1441
- By:
- Publication type:
- Article
Can Digital Health Enable Higher Quality Real‐World Evidence‐Based Decisions?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 45, doi. 10.1002/cpt.1440
- By:
- Publication type:
- Article
Evaluation of Maternal Drug Exposure Following the Administration of Antenatal Corticosteroids During Late Pregnancy Using Physiologically‐Based Pharmacokinetic Modeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 164, doi. 10.1002/cpt.1438
- By:
- Publication type:
- Article
Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 36, doi. 10.1002/cpt.1426
- By:
- Publication type:
- Article
From Discovery to Practice and Survivorship: Building a National Real‐World Data Learning Healthcare Framework for Military and Veteran Cancer Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 52, doi. 10.1002/cpt.1425
- By:
- Publication type:
- Article
Proceedings of a Workshop: US Food and Drug Administration‐International Society of Pharmacometrics Model‐Informed Drug Development in Oncology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 81, doi. 10.1002/cpt.1421
- By:
- Publication type:
- Article
Assessing the Structural and Pharmacological Similarity of Newly Identified Drugs of Abuse to Controlled Substances Using Public Health Assessment via Structural Evaluation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 116, doi. 10.1002/cpt.1418
- By:
- Publication type:
- Article
Real‐World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 84, doi. 10.1002/cpt.1416
- By:
- Publication type:
- Article
Real‐World Data, Advanced Analytics, and the Evolution of Postmarket Drug Safety Surveillance.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 28, doi. 10.1002/cpt.1415
- By:
- Publication type:
- Article
Barriers and Opportunities for Use of Patient Registries in Medicines Regulation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 39, doi. 10.1002/cpt.1414
- By:
- Publication type:
- Article
Real‐World Data and Clinical Pharmacology: A Regulatory Science Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 67, doi. 10.1002/cpt.1413
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 94, doi. 10.1002/cpt.1409
- By:
- Publication type:
- Article
Real‐World Evidence of Treatment Effects: The Useful and the Misleading.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 43, doi. 10.1002/cpt.1405
- By:
- Publication type:
- Article
The US Food and Drug Administration's Real‐World Evidence Framework: A Commitment for Engagement and Transparency on Real‐World Evidence.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 33, doi. 10.1002/cpt.1389
- By:
- Publication type:
- Article
A Drug Is not an Outcome: Extending Translation Through Implementation Using Real‐World Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 47, doi. 10.1002/cpt.1382
- By:
- Publication type:
- Article
Advances in the Use of Real‐World Evidence for Medical Devices: An Update From the National Evaluation System for Health Technology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 30, doi. 10.1002/cpt.1380
- By:
- Publication type:
- Article
Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 211, doi. 10.1002/cpt.1378
- By:
- Publication type:
- Article
A Case‐Crossover–Based Screening Approach to Identifying Clinically Relevant Drug–Drug Interactions in Electronic Healthcare Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 238, doi. 10.1002/cpt.1376
- By:
- Publication type:
- Article
Drug‐Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 245, doi. 10.1002/cpt.1375
- By:
- Publication type:
- Article
Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood–Brain Barrier Measured by Quantitative Targeted Proteomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 228, doi. 10.1002/cpt.1373
- By:
- Publication type:
- Article
Demonstrating Heterogeneity of Treatment Effects Among Patients: An Overlooked but Important Step Toward Precision Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 204, doi. 10.1002/cpt.1372
- By:
- Publication type:
- Article
Effectiveness and Safety of Clopidogrel Co‐administered With Statins and Proton Pump Inhibitors: A Korean National Health Insurance Database Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 182, doi. 10.1002/cpt.1361
- By:
- Publication type:
- Article
Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome‐Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 219, doi. 10.1002/cpt.1359
- By:
- Publication type:
- Article
Switchability of Gabapentin Formulations: A Randomized Trial to Assess Bioequivalence Between Neurontin and Gabasandoz on the Individual Subject Level.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 195, doi. 10.1002/cpt.1353
- By:
- Publication type:
- Article
Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 148, doi. 10.1002/cpt.1211
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 1, doi. 10.1002/cpt.1156
- Publication type:
- Article